Treatment and results of recurrent cancer of corpus uteri in patients receiving anterior and total pelvic exenteration. 1947–1963
✍ Scribed by Hugh R. K. Barber; Alexander Brunschwig
- Publisher
- John Wiley and Sons
- Year
- 1968
- Tongue
- English
- Weight
- 497 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
✦ Synopsis
In cases of cancer corpus uteri in New York state, 30% of these patients have recurrent or persistent disease. The authors question whether further therapy, in the form of exenteration, should be offered to these patients. Of 36 patients receiving pelvic exenteration 5 or more years ago, seven received their initial treatment less than 1 year prior to treatment for recurrence and none survived more than 15 months. Of the 29 patients who were free of disease for at least 1 year after initial treatment and before receiving exenteration for recurrence, five lived 5 or more years. It is concluded that there is a limited place for pelvic exenteration in the treatment of recurrent endometrial cancer.
AND ALL^^ HAS REPORTED THAT THE INCI-
R dence of cancer of the corpus uteri in
New York State has increased from 56.3 to 59.3 per 100,000, while the number of deaths Iias decreased from 24.1 to 17.3 per 100,000. In 1960 nearly 70% of fresh cases of cancer of the corpus uteri reported in 1955 had survived 5 years. Approximately 7% of the p o p illation in this age group (45 to 55) will die d r i i ing a given 5-year period with problems iinrelated to their original cancer. Therefore, bctween 23 and 30% of the patients treated will present with persistent or recurrent cancer.
T h e rcports from the Fourteenth Volume o f the Annual Report' published under the patronage of the international Federation o f Gynecology and Obstetrics report the relative apparent 5-year recovery rate for 14,-796 patients is 62.67". T h e majority of these patients were treated by some form of radiation plus surgery. Following the system adopted for staging corpus cancer in 1950, the results are as follows:
Stage I. T h e growth is confined to the uteriir.
Group I-Operation advisable 77.170
Group 2-kd operative risks 47.57"
1:roni the Mcmorial-James Ewing Hospitals, New 'The authors wish to thank Miss Nelly Schleicher